How is the Glioma Treatment Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the glioma treatment market right now?
The market for glioma treatment has seen a robust expansion in recent years. The market is projected to increase from $5.06 billion in 2024 to $5.39 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.4%. This growth during the historical period is driven by the escalating incidence of gliomas, progress in molecular knowledge, advancements in traditional therapies, progress in clinical trials and research, and enhancements in diagnostic and imaging techniques.
How fast Is the glioma treatment market expected to grow, and what’s its future value?
There is an expected solid surge lined up in the glioma treatment market in the upcoming years. The projection shows a hike up to about $6.97 billion in 2029, advancing at a compound annual growth rate (CAGR) of 6.7%. Huge growth determinants within the forecast period are personalized therapies and biomarker discovery, advancements in immunotherapy, the integration of targeted therapies, revolutionary therapeutic platforms, and joint research ventures. Some noteworthy trends within this period involve agents which penetrate the blood-brain barrier, the utilization of liquid biopsy for tracking, emphasis on the quality of life and supportive care, molecular and genetic subtyping, and patient participation and advocacy.
Get your glioma treatment market report here!
https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report
What are the leading drivers of growth in the glioma treatment market?
The future expansion of the glioma treatment market is expected to be fueled by the increasing interest in personalized medicine. Personalized medicine represents a customized approach to healthcare, considering individual patient traits such as genetics, environment, and lifestyle, with the aim of improving treatment effectiveness and results. The growing preference for this individualized approach to medicine is influenced by a multitude of factors, including advances in genomics, patient empowerment, and enhanced treatment efficiency. The discovery of biomarkers connected to gliomas aids in estimating the response and results of treatment, paving the way for the creation of personalized treatment strategies adapted to each patient’s unique characteristics. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that the FDA had sanctioned 16 new personalized therapies for individuals with rare diseases in 2023. This was in contrast to the six approved in 2022. Thus, the increasing interest in personalized medicine is the main driver of the glioma treatment market’s growth.
What are the key segments defining the glioma treatment market?
The glioma treatment market covered in this report is segmented –
1) By Type: Low-Grade, High-Grade
2) By Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy, Other Treatments
5) By End-User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Low-Grade: Astrocytoma, Oligodendroglioma, Mixed Glioma
2) By High-Grade: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10689&type=smp
Who are the key players steering the development of the glioma treatment market?
Major companies operating in the glioma treatment market include Merck & Co Inc., Amgen Inc., F Hoffmann-La Roche AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics Inc., Bristol-Myers Squibb Co., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Emcure Pharmaceuticals Ltd., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bayer AG, Gilead Sciences Inc., Ipsen Pharma, Eisai Co. Ltd., Genentech Inc., Iovance Biotherapeutics Inc., Agios Pharmaceuticals Inc.
What emerging trends are influencing the growth of the glioma treatment market?
A major trend that is gaining momentum in the glioma treatment market is product innovation. To maintain their market positions, major firms active in the glioma treatment sector are embracing groundbreaking products. For instance, Servier Pharmaceuticals, a pharmaceutical firm from France, received FDA approval for VORANIGO (vorasidenib) tablets in June 2024, a significant development as the inaugural targeted therapy for Grade 2 IDH-mutant glioma. Vorasidenib acts as a dual inhibitor that aims at isocitrate dehydrogenase (IDH) 1 and 2 mutations, which are common in gliomas. These mutations consequently lead to the creation of 2-hydroxyglutarate (2-HG), a metabolite that encourages tumor growth and survival. By inhibiting these enzymes, vorasidenib has the potential to decrease 2-HG levels, which may help in slowing the growth of the tumor.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10689
Which regions are most influential in expanding the glioma treatment market?
North America was the largest region in the glioma treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global glioma treatment market report during the forecast period. The regions covered in the glioma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024
Hemodialysis And Peritoneal Dialysis Global Market Report 2024
Medication Adherence Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medication-adherence-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
